Polymer-Lipid Complexes for High-Loading Solubilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for solubilizing hydrophobic active agents in cosmetics and pharmaceuticals face challenges such as low loading capacity, instability, and irritation, with existing surfactant systems and polymer-lipid complexes being unsuitable for physiological pH and aesthetic considerations.

Innovation Solution

The use of hydrolysed block copolymers of styrene and maleic anhydride to form stable, non-irritating polymer-lipid complexes that allow for high active agent loading and clear aqueous solutions, facilitating enhanced skin penetration and membrane protein solubilization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If surfactant systems are used to solubilize hydrophobic active agents, then solubilization is achieved, but irritation and aesthetic unpleasantness occur

Engineering Contradiction:
Improvesolubilization capacityVSAvoidirritation
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent introduces polymer-lipid complexes as an intermediary system between hydrophobic active agents and aqueous environment. These complexes, formed by hydrophobically associating polymers with phospholipids, serve as a mediator that solubilizes oil-soluble compounds without the irritating effects of conventional surfactants, while maintaining biocompatibility and aesthetic properties

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates composite polymer-lipid structures combining synthetic or natural polymers with phospholipids. This composite approach generates macromolecular assemblies that possess both the solubilization capability needed for hydrophobic compounds and the biocompatibility required to avoid irritation, resolving the contradiction between effectiveness and harmlessness

Inventive Principle:
Principle #40Composite materials

2Reliability

If liposomes are used to deliver active materials, then delivery capability is improved, but loading capacity is low and formulations are rapidly removed from circulation

Engineering Contradiction:
Improvedelivery capabilityVSAvoidloading capacity
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent modifies the structural parameters of delivery systems by using polymer-lipid complexes with adjustable polymer chain lengths, compositions, and cross-linking densities. This allows optimization of both loading capacity and circulation stability, overcoming the limitations of conventional liposomes while maintaining their delivery capability

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If water-in-oil or oil-in-water emulsions are used for skin application, then hydrophobic active agents can be applied, but the formulations are oily to the touch and aesthetically unpleasant

Engineering Contradiction:
Improveapplication capabilityVSAvoidaesthetic appearance
Core Design Contradiction:
Quantity of substanceVSShape

Solution Approach 1:

The invention utilizes phase transition principles by forming polymer-lipid complexes that create clear, non-oily aqueous formulations. The hydrophobic associations and micelle formation represent controlled phase transitions that allow oil-soluble active agents to be delivered in aesthetically pleasing, non-greasy formulations suitable for skin application

Inventive Principle:
Principle #36Phase transitions

4Quantity of substance

If alternating copolymers of styrene and maleic anhydride are used to form macromolecular assemblies, then solubilization is achieved, but the formulations are unstable at physiological pH

Engineering Contradiction:
Improvesolubilization capabilityVSAvoidpH stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent employs polymers with controlled degradation characteristics, where the polymer-lipid complexes are designed to be stable during application but degrade into harmless components after fulfilling their delivery function. This approach accepts controlled short-term instability in exchange for overall system effectiveness and biocompatibility

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention modifies polymer parameters including composition ratios, molecular weight, and cross-linking density to optimize the balance between solubilization capability and pH stability, creating formulations that maintain integrity under physiological conditions while effectively delivering active agents

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrolysed block copolymers provide stable, clear, and non-irritating formulations for hydrophobic active agents, enabling higher loading and improved skin penetration while maintaining clarity and stability at physiological pH.

Implementation Method 1

Hydrophobically associating polymers (also known as amphipols orhypercoiling polymers, due to their amphiphilic character) may associate with phospholipids to form flattened disk-like molecular assemblies

Methodology Applied
Scientific EffectHydrophobic association: Hydrophobe

Implementation Method 2

The use of hydrolysed block copolymers of styrene and maleic anhydride

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentEP1890675B1Compositions comprising a lipid and copolymer of styrene and maleic acid
Publication Date: 2016.12.07 MALVERN COSMECEUTICS LTD
  • EP1890675B1 patent drawing

AI summary

A composition comprising a lipid and copolymer of styrene and maleic acid, wherein the copolymer of styrene and maleic acid is non-alternating, and wherein the polymer and lipid are in the form of macromolecular assemblies.